首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Minor compensatory changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats do not detract from their utility in the study of transporter-mediated pharmacokinetics
【24h】

Minor compensatory changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats do not detract from their utility in the study of transporter-mediated pharmacokinetics

机译:SAGE Mdr1a(P-gp),Bcrp和Mrp2基因敲除大鼠的小补偿性变化不会减损其在转运蛋白介导的药代动力学研究中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Mdr1a-, Bcrp-, and Mrp2-knockout rats are a more practical species for absorption, distribution, metabolism, and excretion (ADME) studies than murine models and previously demonstrated expected alterations in the pharmacokinetics of various probe substrates. At present, gene expression and pathology changes were systematically studied in the small intestine, liver, kidney, and brain tissue from male SAGE Mdr1a, Bcrp, and Mrp2 knockout rats versus wild-type Sprague-Dawley controls. Gene expression data supported the relevant knockout genotype. As expected, Mrp2 knockout rats were hyperbilirubinemic and exhibited upregulation of hepatic Mrp3. Overall, few alterations were observed within 112 ADME-relevant genes. The two potentially most consequential changes were upregulation of intestinal carboxylesterase in Mdr1a knockouts and catechol-O-methyltransferase in all tissues of Bcrp knockout rats. Previously reported upregulation of hepatic Mdr1b P-glycoprotein in proprietary Wistar Mdr1a knockout rats was not observed in the SAGE counterpart investigated herein. Relative liver and kidney weights were 22-53% higher in all three knockouts, with microscopic increases in hepatocyte size in Mdr1a and Mrp2 knockout rats and glomerular size in Bcrp and Mrp2 knockouts. Increased relative weight of clearing organs is quantitatively consistent with reported increases in the clearance of drugs that are not substrates of the knocked-out transporter. Overall, SAGE knockout rats demonstrated modest compensatory changes, which do not preclude their general application to study transporter-mediated pharmacokinetics. However, until future studies elucidate the magnitude of functional change, caution is warranted in rare instances of extensive metabolism by catechol-O-methyltransferase in Bcrp knockouts and intestinal carboxylesterase in Mdr1a knockout rats, specifically for molecules with free catechol groups and esters subject to gutwall hydrolysis.
机译:与鼠模型相比,Mdr1a-,Bcrp-和Mrp2-敲除大鼠是一种更实用的吸收,分布,代谢和排泄(ADME)研究物种,并且先前已证明了各种探针底物的药代动力学方面的预期变化。目前,与野生型Sprague-Dawley对照相比,在雄性SAGE Mdr1a,Bcrp和Mrp2基因敲除大鼠的小肠,肝脏,肾脏和脑组织中,系统地研究了基因表达和病理变化。基因表达数据支持相关的基因敲除基因型。如预期的那样,敲除Mrp2的大鼠具有高胆红素血症,并表现出肝Mrp3的上调。总体而言,在112个与ADME相关的基因中观察到很少的改变。两个潜在的最重要的变化是Bcrp基因敲除大鼠的所有组织中Mdr1a基因敲除的肠内羧酸酯酶的上调和儿茶酚-O-甲基转移酶。在本文研究的SAGE对应物中未观察到以前报道的专有Wistar Mdr1a基因敲除大鼠肝Mdr1b P-糖蛋白的上调。在所有三个基因敲除小鼠中,肝脏和肾脏的相对重量均增加了22-53%,在Mdr1a和Mrp2基因敲除大鼠中肝细胞大小显着增加,在Bcrp和Mrp2基因敲除小鼠中肾小球大小增加。清除器官相对重量的增加与非敲除转运蛋白底物的药物清除率的报告增加在数量上是一致的。总体而言,SAGE基因敲除大鼠表现出适度的代偿性变化,这并不妨碍其普遍用于研究转运蛋白介导的药代动力学。但是,直到未来的研究阐明功能改变的程度之前,在罕见的情况下,在Bcrp基因敲除中的儿茶酚-O-甲基转移酶和Mdr1a基因敲除的大鼠中的肠道羧酸酯酶广泛代谢的罕见情况下,都必须谨慎,特别是对于带有游离邻苯二酚基团的分子和受肠壁作用的酯水解。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号